Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery

<p>Abstract</p> <p>Background</p> <p>Mediastinitis is a severe complication after cardiac surgery. While improvement of prophylaxis and of medical and surgical therapy has reduced its incidence, the treatment of mediastinitis continues to be a challenging problem. Withi...

Full description

Bibliographic Details
Main Authors: Weis Florian, Heyn Jens, Hinske Christian L, Vogt Ferdinand, Weis Marion, Kur Felix, Hagl Christian, Beiras-Fernandez Andres
Format: Article
Language:English
Published: BMC 2012-09-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Online Access:http://www.cardiothoracicsurgery.org/content/7/1/81
_version_ 1819030284419465216
author Weis Florian
Heyn Jens
Hinske Christian L
Vogt Ferdinand
Weis Marion
Kur Felix
Hagl Christian
Beiras-Fernandez Andres
author_facet Weis Florian
Heyn Jens
Hinske Christian L
Vogt Ferdinand
Weis Marion
Kur Felix
Hagl Christian
Beiras-Fernandez Andres
author_sort Weis Florian
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Mediastinitis is a severe complication after cardiac surgery. While improvement of prophylaxis and of medical and surgical therapy has reduced its incidence, the treatment of mediastinitis continues to be a challenging problem. Within this study, we report the successful use of daptomycin as supportive therapy in patients developing mediastinitis after open cardiac surgery.</p> <p>Methods</p> <p>The records of 21 consecutive patients who developed mediastinitis after cardiac surgery were retrospectively reviewed. After diagnosis, all patients received surgical debridement and antibiotic therapy with daptomycin. All patients were followed up to death or discharge.</p> <p>Results</p> <p>Clinical improvement after combined surgical and antibiotic therapy with daptomycin was found in 90.5% of the patients. The median time until clinical improvement occurred was 5 [4/6] days. Daptomycin was well-tolerated and no major adverse events during therapy were observed observed.</p> <p>Conclusions</p> <p>This study provides new and helpful information regarding the beneficial use of daptomycin as supportive treatment option in patients developing mediastinitis after cardiac surgery.</p>
first_indexed 2024-12-21T06:27:42Z
format Article
id doaj.art-365ae76f903847a781edaabdab0c4317
institution Directory Open Access Journal
issn 1749-8090
language English
last_indexed 2024-12-21T06:27:42Z
publishDate 2012-09-01
publisher BMC
record_format Article
series Journal of Cardiothoracic Surgery
spelling doaj.art-365ae76f903847a781edaabdab0c43172022-12-21T19:13:04ZengBMCJournal of Cardiothoracic Surgery1749-80902012-09-01718110.1186/1749-8090-7-81Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgeryWeis FlorianHeyn JensHinske Christian LVogt FerdinandWeis MarionKur FelixHagl ChristianBeiras-Fernandez Andres<p>Abstract</p> <p>Background</p> <p>Mediastinitis is a severe complication after cardiac surgery. While improvement of prophylaxis and of medical and surgical therapy has reduced its incidence, the treatment of mediastinitis continues to be a challenging problem. Within this study, we report the successful use of daptomycin as supportive therapy in patients developing mediastinitis after open cardiac surgery.</p> <p>Methods</p> <p>The records of 21 consecutive patients who developed mediastinitis after cardiac surgery were retrospectively reviewed. After diagnosis, all patients received surgical debridement and antibiotic therapy with daptomycin. All patients were followed up to death or discharge.</p> <p>Results</p> <p>Clinical improvement after combined surgical and antibiotic therapy with daptomycin was found in 90.5% of the patients. The median time until clinical improvement occurred was 5 [4/6] days. Daptomycin was well-tolerated and no major adverse events during therapy were observed observed.</p> <p>Conclusions</p> <p>This study provides new and helpful information regarding the beneficial use of daptomycin as supportive treatment option in patients developing mediastinitis after cardiac surgery.</p>http://www.cardiothoracicsurgery.org/content/7/1/81MediastinitisCardiac surgeryDaptomycin
spellingShingle Weis Florian
Heyn Jens
Hinske Christian L
Vogt Ferdinand
Weis Marion
Kur Felix
Hagl Christian
Beiras-Fernandez Andres
Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery
Journal of Cardiothoracic Surgery
Mediastinitis
Cardiac surgery
Daptomycin
title Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery
title_full Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery
title_fullStr Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery
title_full_unstemmed Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery
title_short Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery
title_sort daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery
topic Mediastinitis
Cardiac surgery
Daptomycin
url http://www.cardiothoracicsurgery.org/content/7/1/81
work_keys_str_mv AT weisflorian daptomycinassupportivetreatmentoptioninpatientsdevelopingmediastinitisafteropencardiacsurgery
AT heynjens daptomycinassupportivetreatmentoptioninpatientsdevelopingmediastinitisafteropencardiacsurgery
AT hinskechristianl daptomycinassupportivetreatmentoptioninpatientsdevelopingmediastinitisafteropencardiacsurgery
AT vogtferdinand daptomycinassupportivetreatmentoptioninpatientsdevelopingmediastinitisafteropencardiacsurgery
AT weismarion daptomycinassupportivetreatmentoptioninpatientsdevelopingmediastinitisafteropencardiacsurgery
AT kurfelix daptomycinassupportivetreatmentoptioninpatientsdevelopingmediastinitisafteropencardiacsurgery
AT haglchristian daptomycinassupportivetreatmentoptioninpatientsdevelopingmediastinitisafteropencardiacsurgery
AT beirasfernandezandres daptomycinassupportivetreatmentoptioninpatientsdevelopingmediastinitisafteropencardiacsurgery